SCHEMBL6469854

SCHEMBL6469854

CCc1[nH]c(SC)nc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 5/20 0.44
HTT P42858 1/20 0.43
KDM4E B2RXH2 1/20 0.38
KDM6B O15054 1/20 0.38
KDM4A O75164 1/20 0.38
KDM4D Q6B0I6 1/20 0.38
HIF1AN Q9NWT6 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PIN1 Q13526 1/20 0.34
CYP2C19 P33261 2/20 0.33
GPR84 Q9NQS5 1/20 0.33
HSD17B10 Q99714 1/20 0.33
POLB P06746 1/20 0.33
PKM P14618 1/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6469858 0.86 HTT (0.38) HCAR2HTTKDM4EKDM6BKDM4A
SCHEMBL6494249 0.73 HCAR2 (0.43) HCAR2PIN1HSD17B10LMNA
SCHEMBL19366154 0.70 PIN1 (0.49) HCAR2PIN1CYP2C19
SCHEMBL2821035 0.70 PIN1 (0.49) HCAR2PIN1CYP2C19POLB
SCHEMBL2824744 0.69 LMNA (0.40) HCAR2HTTKDM4EKDM6BKDM4A
SCHEMBL21843253 0.68 NPC1 (0.48) HCAR2KDM4EMEN1KMT2A
SCHEMBL5552730 0.66 KDM4E (0.43) KDM4EMEN1KMT2APIN1CYP2C19
SCHEMBL15335687 0.66 KDM6B (0.44) HTTKDM4EKDM6BKDM4AKDM4D
SCHEMBL18757854 0.66 XDH (0.39) KDM6BKDM4AKDM4DHIF1ANKDM2A
SCHEMBL8435768 0.66 KDM4E (0.35) HTTKDM4EKDM6BKDM4AKDM4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005011609-A2 TRIAZOLOPURINE-BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME BRISTOL-MYERS SQUIBB COMPANY (US) 2005-02-10 WO disclosed
WO-2004075846-A2 PYRAZOLOPURINE-BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-10 WO disclosed